Journal article

Quality of life related to oral versus subcutaneous iron chelation: A time trade-off study

Richard H Osborne, Richard De Abreu Lourenco, Andrew Dalton, Jennifer Houltram, David Dowton, Douglas Edgar Joshua, Robert Lindeman, Phoebe Joy Ho

VALUE IN HEALTH | ELSEVIER SCIENCE INC | Published : 2007

Abstract

OBJECTIVE: To investigate the utility associated with subcutaneous infusion (deferoxamine) compared with once-daily oral administration (deferasirox) of iron chelation therapy. METHODS: Interviews using the time trade-off technique were used to estimate preferences (utility) for health states by finding the point at which respondents were indifferent between a longer but lower quality of life (QoL) and a shorter time in full health. Participants (n = 110) were community-based, 51% women, median age 35 years, from four regions in Sydney, Australia. Respondents rated three health states involving equal outcomes for people with thalassemia but with different treatment modalities for iron chelat..

View full abstract